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WHAT THIS PAPER ADDS?
 Numerous risk prediction models are available to predict mortality for elective abdominal aortic aneurysm (AAA) repair but
differences in local clinical practice may limit their applicability to individual vascular units. This study developed and validated
a risk prediction model for AAA repair mortality using data from a single vascular unit. This “in-house” risk prediction model
outperformed the other external models in terms of discriminatory ability. However, for purposes of comparative audit between
different units adjusting for case risk, the VGNW or Medicare model should be utilised.a r t i c l e i n f o
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Objectives: To develop and validate an “in house” risk model for predicting perioperative mortality
following elective AAA repair and to compare this with other models.
Design: Multivariate logistics regression analysis was used to identify risk factors for perioperative-day
mortality from one tertiary institution’s prospectively maintained database.
Materials and methods: Consecutive elective open (564) and endovascular (589) AAA repairs (2000e2010)
were split randomly into development (810) and validation (343) data sets. The resultant model was
compared to Glasgow Aneurysm Score (GAS), Modiﬁed Customised Probability Index (m-CPI), CPI, the
Vascular Governance North West (VGNW) model and the Medicare model.
Results: Variables associated with perioperative mortality included: increasing age (P ¼ 0.034),
myocardial infarct within last 10 years (P ¼ 0.0008), raised serum creatinine (P ¼ 0.005) and open
surgery (P ¼ 0.0001). The areas under the receiver operating characteristic curve (AUC) for predicted
probability of 30-day mortality in development and validation data sets were 0.79 and 0.82 respectively.
AUCs for GAS, m-CPI and CPI were poor (0.63, 0.58 and 0.58 respectively), whilst VGNW and Medicare
model were fair (0.73 and 0.79 respectively).
Conclusions: In this study, an “in-house” developed and validated risk model has the most accurate
discriminative value in predicting perioperative mortality after elective AAA repair. For purposes of
comparative audit with case mix adjustments, national models such as the VGNW or Medicare models
should be used.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
For anatomically suitable abdominal aortic aneurysms (AAAs),
endovascular repair (EVAR) is usually the ﬁrst choice of treatmentgery Group, Department of
rt Kilpatrick Clinical Sciences
UK. Tel.: þ44 0116 252 3252.
.ac.uk (E. Choke).
ciety for Vascular Surgery. Publishedue to its early mortality advantages, shorter duration hospital
stays, quicker functional recovery and fewer early postoperative
complications.1 Nevertheless, the decision to choose either open
repair or EVAR may not always be clear-cut. EVAR trials2 have
shown that after 8 years of follow-up, EVAR loses its survival
advantages to open repair. Also, as aneurysm-related re-interven-
tions are more frequent with EVAR, lifelong surveillance is neces-
sary to detect and treat complications such as graft migration,
kinking, fracture, endoleaks and limb outﬂow impairment. Evend by Elsevier Ltd. All rights reserved.
Table 1
Association between preoperative characteristics and perioperative mortality after
abdominal aortic aneurysm repair in 810 patients (development set): univariate
analysis.
No of
patients
(%)
30-day
mortality
(%)
Odds ratio P valuea
Age (years) <77 564 (69.6) 10 (1.8) 2.35 (0.96e5.71) 0.053
77 246 (30.4) 10 (4.1)
Sex M 720 (88.9) 15 (2.1) 2.77 (0.98e7.80) 0.045
F 90 (11.1) 5 (5.6)
Smoking (current
or past)
No 240 (29.6) 9 (3.8) 0.51 (0.21e1.24) 0.127
Yes 570 (70.4) 11 (1.9)
Any myocardial
infarct
No 614 (75.8) 12 (2.0) 2.14 (0.86e5.30) 0.095
Yes 196 (24.2) 8 (4.1)
Recent myocardial
infarct (within
10 years)
No 670 (82.7) 13 (1.9) 2.66 (1.04e6.80) 0.034
Yes 140 (17.3) 7 (5.0)
Respiratory disease No 664 (82.0) 15 (2.3) 1.53 (0.55e4.29) 0.411
Yes 146 (18.0) 5 (3.4)
Antihypertensive
medication
No 409 (50.5) 7 (1.7) 1.92 (0.76e4.88) 0.161
Yes 401 (49.5) 13 (3.2)
Statin medication No 602 (74.3) 15 (2.5) 0.96 (0.35e2.69) 0.944
Yes 208 (25.7) 5 (2.4)
Antiplatelet therapy No 329 (40.6) 7 (2.1) 1.28 (0.50e3.24) 0.605
Yes 481 (59.4) 13 (2.7)
Diabetes mellitus No 740 (91.4) 19 (2.6) 0.55 (0.07e4.17) 0.557
Yes 70 (8.6) 1 (1.4)
Creatinine (mmol/L) 120 628 (77.5) 10 (1.6) 3.59 (1.47e8.78) 0.003
>120 182 (22.5) 10 (5.5)
Previous TIA or
stroke
No 738 (91.1) 19 (2.6) 0.53 (0.07e4.04) 0.536
Yes 72 (8.9) 1 (1.4)
Juxtarenal aneurysm No 759 (93.7) 17 (2.2) 2.73 (0.77e9.64) 0.105
Yes 51 (6.3) 3 (5.9)
Symptomatic
aneurysm
No 716 (88.4) 16 (2.2) 1.94 (0.64e5.95) 0.235
Yes 94 (11.6) 4 (4.3)
Open repair No 419 (51.7) 3 (0.7) 6.30 (1.83e21.69) 0.0009
Yes 391 (48.3) 17 (4.3)
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EVAR in terms of sac shrinkage, the burden of lifelong hospital
appointments, radiation risks and increased costs (if computed
tomography (CT) scan is the method of surveillance) may nullify
the early mortality advantages of EVAR in these young patients
with longer life expectancies.
A clinical tool that can accurately predict individual patients’
perioperative mortality for both treatment options, based on
preoperative data, will help guide clinical decisions. By accurately
estimating individual perioperative mortalities, patients will be
able to provide informed consent whether to accept the risk of
higher mortality from open repair versus the signiﬁcant risks of
long term complications and need for life-long surveillance of
endovascular repair. Other authors3 have also suggested that such
risk prediction models can be used to calculate and publish risk-
adjusted surgeon-speciﬁc mortality data for AAA surgery so that
fairer comparison between hospitals can be made. This may avoid
surgeons turning down high risk patients.
Numerous predictive risk models exist but each has its limita-
tions.4 The early pre-EVAR models were derived for open AAA
repair only,5 which overestimate mortality in the EVAR pop-
ulation.6,7 Some models were developed from combination of both
emergency and elective AAA patients,8 and are of less relevance to
elective AAA repair. To date there have been two models developed
speciﬁcally for elective open and EVAR patients; the Vascular
Governance North West (VGNW) model3 and the Medicare pop-
ulation model.9 These need to be externally validated and their
accuracy may be subject to variations in local practice.
This study aimed to develop and validate an “in-house” risk
model for predicting 30-day mortality following elective AAA
repair in a single vascular unit and to compare this with other
models.a Chi-square test.Methods
Data set
Data were collected prospectively on 1153 consecutive AAA
repairs carried out between January 2000 and October 2010 in
University Hospitals of Leicester NHS Trust using a standardised
proforma. This proforma was a modiﬁcation of the National
Vascular Database AAA proforma. Demographic variables analysed
are listed in Table 1. The primary endpoint was perioperative
mortality, deﬁned as in-hospital death or death within 30 days of
the procedure. Any deaths occurring after discharge but within 30
days were identiﬁed using Patient Centre mortality database.Statistical analysis
All statistical analysis was performed with SPSS for Windows
version 18. Data were split randomly into a development data set
(810, 70.0 per cent) and a validation data set (343, 30.0 per cent),
which is standard statistical practice for developing and validating
a logistic model.
Development of risk model
Univariate exploratory analysis was ﬁrst performed on the
development data set. The c2 test was performed for categorical
variables and standard statistical tests were used to calculate odds
ratios and 95 per cent conﬁdence intervals. Candidate variables
with P < 0.100 were entered into the multivariate model using
a forward stepwise logistic regression analysis, to identify risk
factors for perioperative mortality. Risk factors were retained for
the ﬁnal model if the P value was below 0.050. The relativecontribution of each variable to the prediction of perioperative
mortality was calculated.
Risk model performance
Discrimination is usually assessed by the area under the receiver
operating characteristic curve (AUC), also known as C statistic.
Calibration was assessed using the HosmereLemeshow test, which
examines how well the percentage of observed perioperative
mortality matches the percentage of expected perioperative
mortality over deciles of predicted risk. If the model calibrates well,
there will not be a substantial deviation from the 45 line of perfect
ﬁt.
Risk model validation
Once the model was trained on the basis of the development
data set, the validation data set was used to validate the model. The
model validation applied the trained model from the development
data set to estimate perioperative mortality probabilities for all
patients in the validation data set. These expected probabilities
were then compared with observed perioperative mortality status
in the validation data set by computing the AUC (discrimination) to
determine the predictive accuracy of the trained model has on the
validation data set. If this AUC shows favourable predictive accuracy
(>0.70), then the model is considered validated.
Comparison with other risk prediction models
To compare the “in house” developed and validated risk
predictor with other models, risk factors from to Glasgow Aneu-
rysm Score (GAS), Modiﬁed Customised Probability Index (m-CPI),
Figure 1. Observed and expected perioperative mortality compared for ten groups of
increasing risk in the development data set P ¼ 0.912 (HosmereLemeshow goodness-
of-ﬁt test).
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patients in our data set. The AUC was used to compare the
discriminatory performance of the “in-house” risk calculator with
that of the other models. GAS, m-CPI and CPI models were chosen
to represent earlier risk predictor models that did not include EVAR
in their development. The VGNW and Medicare models were
selected as contemporary models that were developed from both
elective open AAA and EVAR.
Results
Demographics (development data set)
Of the 810 patients undergoing elective AAA repair in the
development data set, 20 (2.5 per cent) died. EVAR was performed
in 419 patients (51.7 per cent) and open repair in 391 (48.3 per
cent), with perioperative mortality rates of 0.7 and 4.3 per cent
respectively. Main patient characteristics are reported in Table 1.
Most procedures (759, 93.7 per cent) were for infrarenal AAA. The
majority of patients were men (88.9 per cent) and the median age
was 72.3 years.
Univariate analysis (development data set)
Table 1 shows the inﬂuence of preoperative patient character-
istics on perioperative mortality determined by univariate analysis.
Increasing age, female sex, any history of myocardial infarct, recent
history of myocardial infarction (within 10 years of operation),
creatinine >120 mmol/L and open repair were signiﬁcantly associ-
ated with perioperative mortality (P < 0.100) and were selected to
enter into the model.
Multivariate analysis and development of risk model (development
data set)
The risk factors for perioperative mortality in the full model
were: increasing age (P¼ 0.034), myocardial infarct within 10 years
(P ¼ 0.0008), creatinine levels (P ¼ 0.005) and open repair
(P ¼ 0.0001) (Table 2). The area under the ROC curve for the
multivariate prediction model in the development set was 0.79.
Fig. 1 shows that the calibration (HosmereLemeshow goodness-of-
ﬁt test) was excellent, without substantial deviation from the 45
line of perfect ﬁt (P ¼ 0.912). The logistic regression equation for
calculating risk of 30-day mortality is shown in Table 2.
Validation of risk model (validation data set)
In the validation data set, 13 patients (3.8 per cent) died.
Applying the logistic regression equation to the validation data setTable 2
Final logistic regression model for perioperative mortality after AAA repair.
Coefﬁcient P Odds ratio
Age (years) 0.080 0.0340 1.08 (1.00e1.17)
Recent myocardial infarct
(within 10 years)
1.339 0.0008 3.81 (1.42e10.22)
Open repair 2.370 0.0001 10.70 (2.82e40.63)
Creatinine (mmol/L) 0.005 0.005 1.01 (1.001e1.008)
Constant 12.093
Calculation of predicted risk using patient data and logistic regression coefﬁcients:
odds of perioperative mortality ¼ exp (12.093 þ [0.080  age (continuous in
years)] þ [1.339  recent myocardial infarct] þ [2.370  open
repair]þ [0.005 creatinine (mmol/L)]). The coefﬁcient value is multiplied by 1 if the
risk factor is present, and by 0 if absent. Predicted risk of 30-day mortality as
a percentage ¼ [odds/(1 þ odds)]  100.of 343 elective EVAR and open AAA repairs produced an area under
the ROC curve of 0.82 (95% Conﬁdence Interval (CI) 0.72e0.92),
which indicates good discrimination. These ﬁndings indicated
that the model continued to perform with good discrimination in
the independent and randomly generated validation data set.
Low-, intermediate- and high-risk groupswere created based on
the predicted risk of 30-day mortality. Low-risk patients had
a maximum risk of 3.5%, medium-risk patients had a risk between
3.5 and 6.5%, whereas in high-risk patients the risk of death within
30 days was greater than 6.5%. After stratifying the patients into
risk groups, the observed versus predicted 30-daymortality was 1.9
versus 1.4% in low-risk, 8.0 versus 4.6% in intermediate-risk and
14.3 versus 11.3% in high-risk patients.Comparison with other risk prediction models
The formulae for risk calculation for GAS, m-CPI, CPI, VGNWand
Medicare are shown in Table 3. When applied to only the validation
data set (n ¼ 343), the areas under the ROC curve for GAS, m-CPI,
CPI and VGNW were 0.57 (95% CI 0.44e0.71), 0.58 (95% CI 0.47e
0.70), 0.58 (95% CI 0.45e0.70) and 0.63 (95% CI 0.51e0.74)
respectively, which indicated poor discriminatory value. Area
under the ROC curve for Medicare population model was 0.78 (95%
CI 0.68e0.88) which indicated a fair discrimination.
When applied to the entire data set (both development and
validation data sets, n ¼ 1153), the areas under the ROC curve for
GAS, m-CPI and CPI were 0.63 (95% CI 0.55e0.71), 0.58 (95% CI
0.49e0.68) and 0.58 (95% CI 0.49e0.67), respectively, which indi-
cated poor discriminatory value. Areas under the ROC curve for
VGNW and Medicare population model were 0.73 (95% CI 0.65e
0.81) and 0.79 (95% CI 0.73e0.86) respectively, which indicated
a fair discrimination. Comparison of the risk predictor character-
istics of patients in Leicester, VGNW and Medicare population
revealed that patient proﬁles in terms of risk predictor variables
were signiﬁcantly different in all cases (Table 4).Analyses using only open AAA patients
As the majority of perioperative mortality was accounted for by
the open AAA repair group, this study performed a subset analyses
of only open AAA repair patients (n ¼ 564). These were similarly
Table 3
Risk-scoring formulae and AUCs for GAS, m-CPI and CPI, VGNW and Medicare models.
Scoring system formula Formula AUC
Modiﬁed Customised Probability Index (m-CPI) CAD (þ13); CCF (þ14); BP (þ7); COPD (þ7); RF (þ16); B-blocker (15);
statin (10)
0.58
Customised Probability Index (CPI) CAD (þ13); CCF (þ14); CVD (þ10); BP (þ7); COPD (þ7); RF (þ16);
B-blocker (15); statin (10)
0.58
Glasgow Aneurysm Score (GAS) Age þ CAD (þ7); CVD (þ10); RF (þ14) 0.63
Vascular Governance North West of
England model
Odds ¼ Exp (9.3431 þ [0.0486  age] þ [0.7322  female sex] þ
[0.6620  diabetes] þ [0.0073  creatinine (mmol/l)] þ [0.4718 
respiratory disease] þ [0.7762  antiplatelet medication] þ
[1.3130  open surgery])
0.73
Medicare model Odds ¼ Exp (5.02 þ [0.42  Female] þ [0.15  Age (70e75)] þ
[0.63  Age (75e80)] þ [1.14  Age (80)] þ [0.71  CRI] þ
[0.95  ESR] þ [0.55  CHF] þ [0.30  Vascular Disease] þ
[1.17  Open Repair]
0.79
Leicester See Table 2 0.82
Deﬁnitions:
GAS, m-CPI and CPI: CAD, coronary artery disease (MI, revascularisation, angina, severe valve disease* or arrhythmia*); CVD, cerebrovascular disease (stroke, TIA); RF renal
failure (creatinine >180 mmol/l); CCF, uncontrolled congestive cardiac failure; COPD, chronic obstructive pulmonary disease; BP, treated hypertension, *m-CPI only.
VGNW model: Respiratory disease (history of respiratory disease with dyspnoea on exertion or at rest); diabetes (diet-controlled or insulin dependent).
Medicare model: CRI, chronic renal insufﬁciency; ESR, end stage renal; CHF, congestive heart failure; Vascular disease (cerebrovascular or peripheral vascular disease).
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(n ¼ 173). By univariate analysis, increasing age, recent history of
myocardial infarction (within 10 years of operation), creatinine
>120 mmol/L and history cerebrovascular disease were signiﬁcantly
associated with perioperative mortality (P < 0.100) and were
selected to enter into the ﬁnal model. The risk factors for peri-
operative mortality in the full model were: increasing age
(P ¼ 0.03) and creatinine levels (P ¼ 0.01) (Table 5). When this
logistic regression equationwas applied to the validation data set of
173 elective open AAA repairs, it produced an area under the ROC
curve of 0.68 (95% CI 0.52e0.83). The large conﬁdence interval
prevented anymeaningful conclusion on the level of discrimination
due to high uncertainty about the precision.
Discussion
This study has demonstrated the feasibility of using data from
a single vascular unit to develop and validate an accurate multi-
variable preoperative risk prediction model for 30-day mortality
following elective EVAR and open AAA repair. This “in-house”
model allocates an independent weight to the type of repair (open
or EVAR) and three preoperative patient characteristics (age,
creatinine levels and myocardial infarct within ten years) to
calculate the overall risk. Good discriminatory ability and calibra-
tion was exhibited by this model. Compared to other risk predictor
models, this model demonstrated the most accurate discrimination
between cases (perioperative mortality) and non-cases. It was notTable 4
Comparison of risk predictor characteristics of patients in the Leicester, VGNW and Med
Leicester 810 patients (%)
Age (years) >70 60.1
75 40.4
Female 11.1
Congestive heart failure 4.0
Respiratory disease 18.0
Antiplatelet therapy 59.4
Diabetes mellitus 8.6
Creatinine (>120 mmol/L) 22.5
Vascular disease (CBVD or PVD) 10.0
End stage renal failure 2.2
Open repair 48.3
PVD, peripheral vascular disease; CBVD, cerebrovascular disease.
a Chi-square test.
b Chronic renal insufﬁciency in the Medicare population taken as creatinine level >12possible to develop a riskmodel based on EVAR only patients due to
the lowmortality rate in this group. Conversely when only the open
AAA repair patients were analysed, the ﬁnal model using age and
preoperative creatinine levels demonstrated poor discrimination
and was not ﬁt for purpose.
Bohm et al10 reported that both CPI and m-CPI predicted poorly
for early mortality and morbidity when these scoring systems were
applied to their EVAR patients. Similarly in the present study, we
found poor perioperative mortality discriminatory values for CPI
and m-CPI for our cohort of open and EVAR patients. Various risk
prediction models have been developed speciﬁcally for AAAs.
However, the earlier models also did not include EVAR patients in
their development. GAS,8 the most well-known model, also
included ruptured AAAs in its analysis (resulting in high overall
mortality of 20%), thereby further restricting its applicability to
a contemporary series of elective open and EVAR patients. There-
fore it is not unexpected to ﬁnd that studies which incorporated
EVAR cases,10e12 including ours, have conﬁrmed poor discrimina-
tory value of GAS.
The Leiden score7 and a risk model constructed from the UK
Small Aneurysm Trial (UKSAT) data6 were developed wholly on
open elective AAA repairs. A subsequent study reported that the
Leiden risk model was useful in identifying a low-risk group, but
the UKSAT risk model showed a relatively poor performance.13
These two models were not tested on our patients as the Leiden
score required ECG assessment for ischaemia and the UKSAT model
required FEV1 data; and both assessment criteria were noticare population.
VGNW 1936 patients (%) Medicare 22,830 patients (%) P valuea
e 85.6 0.0001
32.2 e 0.0001
17.7 19.7 0.0001
Data not available 13.2 0.0001
28.2 29.6 0.0001
50.9 Data not available 0.0001
8.9 15.9 0.0001
19.6 4.2b 0.0001
Data not available 31.5 0.0001
Data not available 0.7 0.0001
81.1 50.0 0.0001
0 mmol/L (deﬁnition of chronic renal insufﬁciency not provided).
Table 5
Final logistic regression model for perioperative mortality after open AAA repair.
Coefﬁcient P value Odds ratio
Age (years) 0.095 0.031 1.10 (1.01e1.20)
Creatinine (mmol/L) 0.007 0.014 1.01 (1.00e1.012)
Constant 9.848
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unlikely that the Leiden score could achieve accurate discrimina-
tion in our cohort of patients, as the overall mortalities in the Leiden
data were 7.3% and 6.8% depending on the data source, which were
substantially higher than any modern series of elective EVAR and
open AAA repair.
The Australian model14 has been developed on exclusively non-
ruptured EVAR procedures. This model includes assessment of AAA
neck morphology (diameter, angulation and length). At present
more numbers are needed before this model can be tested on our
EVAR patients due to the very low mortality in the EVAR group
(0.7%).
There are currently two risk prediction models that have been
created using both elective EVAR and open AAA data; the Medicare
database9 and more recently the VGNW programmemodel.3 These
models achieved fair discriminatory values in predicting peri-
operative mortalities on our elective open and EVAR patients and
either would therefore be a moderately useful tool for preoperative
counselling of peri-operative mortality for our patients; with the
Medicare model outperforming the VGNW model. These ﬁndings
suggested that the most useful risk prediction models for
contemporary AAA series are those that were derived from both
elective EVAR and open AAA data.
Our model used four readily available preoperative character-
istics compared to the seven variables utilised by the VGNW and
Medicare models. Even with the smallest patient population in the
development set, this “in-house”model still outperformed both the
VGNW and Medicare models. These ﬁndings suggest that the
“bespoke” nature of a locally developed risk model is more
important to the discriminative accuracy of the model than the
sample size. This in itself is not surprising since this model was
developed from patients operated on by the same surgeons, with
the same anaesthetic and ICU back up, and the same theatre team.
This study also conﬁrmed that the three models used development
data sets with very different patient risk predictor proﬁles. This
may reﬂect either differences in local demographics or differences
in local practices, such as selection of cases, between the three
different populations. For example, the youngest patient in the
Medicare population was 67 years old and Giles et al9 have
acknowledged that if younger patients were included, it is likely
that agewould carry a different weight andwouldmore likely be an
even stronger predictor. Such considerations would appear to be
the likely explanation for why the “in-house” model had the
highest discriminatory value.
We would therefore utilise our “in house” model for accurate
counselling of patients preoperatively. However for purposes of
comparative audit and case mix adjustment, it would be more
appropriate to use national models such as the VGNW or Medicare
models. The inherent danger of each unit developing its ownmodel
for purposes of comparative audit is that poorly performing units
with high mortalities can develop a model that will predict higher
mortality and therefore continue to have higher than nationally
accepted mortalities but this will not be highlighted by their “in
house”model. A model needs to be generalisable across many units
to allow its use in comparative audit and this study has externally
validated the use of the VGNWand Medicare model in this respect.
Another point to consider was that our model performed better forlow risk groups andwas less accurate for intermediate and high risk
groups.
Limitations
Despite the data set being fairly comprehensive, information on
other potential predictive factors, such as ECG evidence of
ischaemia and FEV1, whichmay affect outcomes were not available.
There is therefore potential scope for improvement of accuracy of
this model. Secondly, the number of deaths in both development
and validation data sets were small and this may affect accuracy of
the model. Thirdly, this model does not incorporate aneurysm
morphological data which may be especially important for EVAR
patients. Fourthly, analysis of open repair only patients produced
a model that was found to have poor discriminatory value would
suggest that the good discriminatory performance of the full model
(including both open and EVAR patients) is primarily due its ability
to distinguish between open and EVAR. This raises the question of
how useful the model is with regards to discrimination using other
patient characteristics and to some extent limits the value of the
full prediction model. As patients in this study represent a non-
randomised cohort, case mix in the data is likely to inﬂuence the
observed outcomes of the two surgical strategies. This may limit
accurate risk-prediction at an individual level to allow a choice
between EVAR or open repair.
Conclusions
A locally developed and validated “in-house” model demon-
strated better performance compared to other risk predictor
models in predicting perioperative mortality for elective open and
endovascular AAA repair. The VGNW and Medicare models
demonstrated fair accuracies when tested on our patients. These
models were developed speciﬁcally for elective open AAA and
EVAR patients and would therefore be applicable as accurate tools
for comparative audit and case mix adjustment. Older models that
included ruptured AAA repairs in their development or those that
excluded EVAR patients should be applied with caution to
contemporary series of AAA patients.
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